联环药业 (600513.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(联环药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 50.0045.0049.0048.0061.0051.0051.0050.00
 单季度销售净利率(%) 7.006.006.008.008.008.008.009.00
 单季度净资产收益率ROE(%) 3.002.002.002.003.003.003.003.00
 单季度总资产净利率ROA(%) 2.001.001.001.002.002.002.002.00
单季度财务摘要:
 单季度营业总收入(元) 690,695,005.00528,755,530.00502,969,054.00451,680,717.00542,873,264.00515,595,632.00492,328,671.00404,359,214.00
 单季度营业总成本(元) 644,188,990.00489,859,824.00469,042,986.00413,066,961.00492,281,110.00465,834,560.00442,580,260.00363,768,187.00
 单季度营业收入(元) 690,695,005.00528,755,530.00502,969,054.00451,680,717.00542,873,264.00515,595,632.00492,328,671.00404,359,214.00
 单季度营业利润(元) 57,373,961.0039,920,277.0035,939,172.0041,538,556.0045,725,650.0048,915,941.0047,955,955.0044,448,639.00
 单季度利润总额(元) 58,179,564.0039,813,060.0035,407,457.0041,631,975.0048,370,605.0048,796,207.0047,566,623.0044,319,536.00
 单季度净利润(元) 50,743,309.0032,894,992.0032,641,515.0035,060,508.0046,018,716.0041,168,852.0041,771,987.0037,482,657.00
 单季度归属母公司股东的净利润(元) 46,166,713.0027,314,035.0030,407,839.0031,119,933.0042,082,444.0033,630,926.0035,247,411.0030,409,747.00
 单季度经营活动产生的现金流量(元) 171,346,884.00-16,062,883.0021,444,188.00-16,026,393.00156,467,526.00-3,719,865.001,592,557.00-26,749,729.00
 单季度投资活动产生的现金流量(元) -52,991,999.00-31,626,189.00-52,622,547.00-47,453,147.00-58,038,951.00-14,685,125.00-44,679,257.00-103,280,313.00
 单季度筹资活动产生的现金流量(元) -43,807,590.0034,907,267.00-17,095,557.00-9,101,987.009,312,995.008,312,325.00-2,080,235.0061,378,083.00
 单季度现金及现金等价物净增加(元) 74,357,490.00-12,720,007.00-47,663,765.00-72,831,450.00107,810,637.00-9,819,396.00-43,057,400.00-68,790,341.00

前瞻产业研究院